Ludwig Englmeier

1.9k total citations · 1 hit paper
10 papers, 1.6k citations indexed

About

Ludwig Englmeier is a scholar working on Molecular Biology, Infectious Diseases and Virology. According to data from OpenAlex, Ludwig Englmeier has authored 10 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 2 papers in Infectious Diseases and 1 paper in Virology. Recurrent topics in Ludwig Englmeier's work include RNA Research and Splicing (7 papers), Nuclear Structure and Function (6 papers) and COVID-19 Clinical Research Studies (2 papers). Ludwig Englmeier is often cited by papers focused on RNA Research and Splicing (7 papers), Nuclear Structure and Function (6 papers) and COVID-19 Clinical Research Studies (2 papers). Ludwig Englmeier collaborates with scholars based in Germany, Netherlands and Denmark. Ludwig Englmeier's co-authors include Iain W. Mattaj, Jean‐Christophe Olivo, Torben Heick Jensen, Peter Askjaer, Jørgen Kjems, Jakob Nilsson, Maarten Fornerod, Carlo Petosa, F. Ralf Bischoff and Ulrike Kutay and has published in prestigious journals such as Journal of Biological Chemistry, Annual Review of Biochemistry and Molecular and Cellular Biology.

In The Last Decade

Ludwig Englmeier

10 papers receiving 1.6k citations

Hit Papers

NUCLEOCYTOPLASMIC TRANSPORT: The Soluble Phase 1998 2026 2007 2016 1998 250 500 750 1000

Peers

Ludwig Englmeier
Katrin Stade Germany
Laura I. Davis United States
Patricia Jans Australia
W. Matthew Michael United States
Béatrice Kunz Switzerland
Christopher Tipper United States
Iris Kemler United States
Katrin Stade Germany
Ludwig Englmeier
Citations per year, relative to Ludwig Englmeier Ludwig Englmeier (= 1×) peers Katrin Stade

Countries citing papers authored by Ludwig Englmeier

Since Specialization
Citations

This map shows the geographic impact of Ludwig Englmeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ludwig Englmeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ludwig Englmeier more than expected).

Fields of papers citing papers by Ludwig Englmeier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ludwig Englmeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ludwig Englmeier. The network helps show where Ludwig Englmeier may publish in the future.

Co-authorship network of co-authors of Ludwig Englmeier

This figure shows the co-authorship network connecting the top 25 collaborators of Ludwig Englmeier. A scholar is included among the top collaborators of Ludwig Englmeier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ludwig Englmeier. Ludwig Englmeier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Englmeier, Ludwig, et al.. (2022). What’s happening where when SARS-CoV-2 infects: are TLR7 and MAFB sufficient to explain patient vulnerability?. Immunity & Ageing. 19(1). 6–6. 8 indexed citations
2.
Englmeier, Ludwig. (2020). A theory on SARS-COV-2 susceptibility: reduced TLR7-activity as a mechanistic link between men, obese and elderly.. Journal of Biological Regulators and Homeostatic Agents. 34(3). 1125–1129. 13 indexed citations
3.
Wiechens, Nicola, et al.. (2004). Nucleo-cytoplasmic Shuttling of Axin, a Negative Regulator of the Wnt-β-Catenin Pathway. Journal of Biological Chemistry. 279(7). 5263–5267. 70 indexed citations
4.
Luque, Carlos M., et al.. (2003). An Alternative Domain Containing a Leucine-rich Sequence Regulates Nuclear Cytoplasmic Localization of Protein 4.1R. Journal of Biological Chemistry. 278(4). 2686–2691. 18 indexed citations
5.
Kuersten, Scott, Gert‐Jan Arts, Tobias C. Walther, Ludwig Englmeier, & Iain W. Mattaj. (2002). Steady-State Nuclear Localization of Exportin-t Involves RanGTP Binding and Two Distinct Nuclear Pore Complex Interaction Domains. Molecular and Cellular Biology. 22(16). 5708–5720. 38 indexed citations
6.
Englmeier, Ludwig, Maarten Fornerod, F. Ralf Bischoff, et al.. (2001). RanBP3 influences interactions between CRM1 and its nuclear protein export substrates. EMBO Reports. 2(10). 926–932. 94 indexed citations
7.
Englmeier, Ludwig, Jean‐Christophe Olivo, & Iain W. Mattaj. (1999). Receptor-mediated substrate translocation through the nuclear pore complex without nucleotide triphosphate hydrolysis. Current Biology. 9(1). 30–41. 139 indexed citations
8.
Askjaer, Peter, Torben Heick Jensen, Jakob Nilsson, Ludwig Englmeier, & Jørgen Kjems. (1998). The Specificity of the CRM1-Rev Nuclear Export Signal Interaction Is Mediated by RanGTP. Journal of Biological Chemistry. 273(50). 33414–33422. 182 indexed citations
9.
Mattaj, Iain W. & Ludwig Englmeier. (1998). NUCLEOCYTOPLASMIC TRANSPORT: The Soluble Phase. Annual Review of Biochemistry. 67(1). 265–306. 1029 indexed citations breakdown →
10.
Arts, Gert‐Jan, Ludwig Englmeier, & Iain W. Mattaj. (1997). Energy- and Temperature-Dependent In Vitro Export of RNA from Synthetic Nuclei. Biological Chemistry. 378(7). 641–9. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026